Humira and Botox maker AbbVie is suing the Trump administration to get a clearer definition of who counts as an eligible ...
April 8 (Reuters) - AbbVie has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible for ...
AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...
Hospital groups and 340B advocates counter that the discounts are a financial lifeline that helps fund community health ...
TrumpRX, a newly launched prescription discount program, is being promoted as a way for consumers to save money on medications at participating pharmacies nationwide. Supporters say the program is ...
The secretary of Indiana’s Family and Social Services Administration wants to change how hospitals purchase discounted drugs ...
Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the ...
Prescription drug costs in the U.S. are famously confusing, and for millions of Americans, increasingly unaffordable. While health insurance is designed to protect against high costs, it doesn't ...
Expansion from 10,000 to over 280,000 users in twelve months underscores growing adoption of prescription price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results